A Population-Based Pharmacokinetic Model Approach to Pantoprazole Dosing for Obese Children and Adolescents. [PDF]
Paediatr Drugs, 2018 Shakhnovich V +10 more
europepmc +1 more source
Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response. [PDF]
Oncotarget, 2017 Guo D, Wang C, Wang Q, Qiao Z, Tang H.
europepmc +1 more source
Pantoprazole Does Not Reduce the Antiplatelet Effect of Clopidogrel: A Randomized Controlled Trial in Korea. [PDF]
Gut Liver, 2017 Choi YJ +11 more
europepmc +1 more source
Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study. [PDF]
Eur J Clin Pharmacol, 2018 Jin BH +6 more
europepmc +1 more source
Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study. [PDF]
Int J Mol Sci, 2016 Kruszelnicka O +5 more
europepmc +1 more source
A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance. [PDF]
Antimicrob Agents Chemother, 2017 Tsay FW +10 more
europepmc +1 more source
Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms. [PDF]
PLoS One, 2018 Corsello A +12 more
europepmc +1 more source
Proton pump inhibitor ilaprazole suppresses cancer growth by targeting T-cell-originated protein kinase. [PDF]
Oncotarget, 2017 Zheng M +9 more
europepmc +1 more source
Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial. [PDF]
Medicine (Baltimore), 2015 Hauser G +4 more
europepmc +1 more source